Dr. Charles Wykoff Interviews Karl Csaky MD, PhD Discussing Faricimab for DME and nAMD
Join us in a discussion with Dr. Charles Wykoff & Karl Csaky MD, PhD on Faricimab for DME and nAMD. Interpreting the Durability Signals from the Phase 3 Programs.
On this page
faricimab
Explore "faricimab" with insightful episodes like "Dr. Charles Wykoff Interviews Karl Csaky MD, PhD Discussing Faricimab for DME and nAMD" and "Dr. Carmen Puliafito Interviews Charles Wykoff MD, PhD: Faricimab Results in DME & nAMD" from podcasts like ""Retina Synthesis" and "Retina Synthesis"" and more!
Episodes (2)
Dr. Carmen Puliafito Interviews Charles Wykoff MD, PhD: Faricimab Results in DME & nAMD
Join us as Dr. Carmen Puliafito and Charles Wykoff MD, PhD speak about the results. 1 of 3 total parts to "Interpreting Faricimab Phase 3 Data in DME & nAMD"